A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate the efficacy and safety of adjuvant autogene cevumeran plus atezolizumab and modified leucovorin, 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (mFOLFIRINOX) versus mFOLFIRINOX alone in participants with resected pancreatic ductal adenocarcinoma (PDAC) who have not received prior systemic anti-cancer treatment for PDAC and have no evidence of disease after surgery.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rak trzustki.
- •Rak trzustki o określonym stopniu zaawansowania (T1-T3, N0-N2, M0).
- •Całkowite usunięcie guza raka trzustki podczas operacji.
- •Brak widocznych oznak raka po operacji.
- •Poziom markera CA19-9 zmierzony przed rozpoczęciem badania.
- •Od operacji raka trzustki minęło od 6 do 12 tygodni.
- •Pełne wyzdrowienie po operacji i zdolność do przyjęcia leczenia.
- •Kobiety w wieku rozrodczym muszą unikać ciąży.
✗ Disqualifies
- •Otrzymanie jakiegokolwiek leczenia raka trzustki przed operacją.
- •Planowane dodatkowe leczenie antynowotworowe po tym badaniu.
- •Brak śledziony.
- •Uczucie drętwienia lub mrowienia (neuropatia) o znacznym nasileniu przed badaniem.
- •Stwierdzony niedobór enzymu DPD.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (89)
USC Norris Comprehensive Cancer Center
Los Angeles, United States
USC Norris Cancer Center
Newport Beach, United States
University of California, San Francisco (UCSF)
San Francisco, United States
University of California Los Angeles
Santa Monica, United States
St. Francis Hospital and Medical Center
Hartford, United States
Smilow Cancer Center
New Haven, United States
Yale Cancer Center
New Haven, United States
Smilow Cancer Hospital Care Center at Trumbull
Trumbull, United States
Northwestern Memorial Hospital
Chicago, United States
Indiana University Health Melvin & Bren Simon Cancer Center
Indianapolis, United States
University of Kentucky Medical Center
Lexington, United States
Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center
Boston, United States
Boston Medical Center (BMC) - Cancer Care Center
Boston, United States
Henry Ford Health System
Detroit, United States
University of Nebraska
Omaha, United States
Memorial Sloan Kettering Cancer Center Basking Ridge
Basking Ridge, United States
Memorial Sloan Kettering Cancer Center
Middletown, United States
Memorial Sloan Kettering Cancer Center at Bergen
Montvale, United States
Memorial Sloan Kettering Cancer Center - Commack
Commack, United States
Memorial Sloan Kettering Cancer Center at Westchester
Harrison, United States
Northwell Health
Lake Success, United States
NYU Langone Health
New York, United States
Mount SInai Medical Center
New York, United States
Columbia University Medical Center
New York, United States
MEETH-LHH Northwell Health Cancer Clinical Trials Office at MEETH-LHH
New York, United States
Memorial Sloan Kettering Cancer Center
New York, United States
Memorial Sloan Kettering Cancer Center at Nassau
Uniondale, United States
Duke Cancer Institute
Durham, United States
University of Cincinnati Cancer Institute
Cincinnati, United States
Rhode Island Hospital
Providence, United States
Miriam Hospital
Providence, United States
Fred Hutchinson Cancer Research Center
Seattle, United States
Antwerp University Hospital
Edegem, Belgium
ULB Hôpital Erasme
Brussels, Belgium
AZ Maria Middelares
Ghent, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
St Michael Hospital
Toronto, Canada
Princess Margaret Cancer Center
Toronto, Canada
Centre Hospitalier de l'Universite de Montreal - Notre - Dame Hos pital
Montreal, Canada
Jewish General Hospital
Montreal, Canada
Centre Hospitalier Régional Universitaire de Lille
Lille, France
Centre Leon Berard
Lyon, France
Institut Paoli Calmettes
Marseille, France
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France
Gustave Roussy
Villejuif, France
Charite-Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK)
Berlin, Germany
Katholisches Klinikum Bochum gGmbH;St. Josef-Hospital
Bochum, Germany
Universitaetsklinikum Koeln
Cologne, Germany
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, Germany
Universitätsklinikum Essen
Essen, Germany
Krankenhaus Nordwest GmbH
Frankfurt, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Universitaetsklinikum Heidelberg
Heidelberg, Germany
Ludwig-Maximilians-Universität München
München, Germany
Klinikum Bogenhausen
München, Germany
Universitaetsklinikum Tuebingen
Tübingen, Germany
Universitätsklinikum Ulm, Klinik für Innere MedizinInnere Medizin III Studienzentrale
Ulm, Germany
Uniklinikum Würzburg, Med. Klinik und Poliklinik II
Würzburg, Germany
Amsterdam UMC Location VUMC
Amsterdam, Netherlands
UMC Radboud Nijmegen
Nijmegen, Netherlands
Erasmus MC
Rotterdam, Netherlands
National Cancer Center (NCC) Hospital - Center for Liver and Pancreatobiliary Cancer
Goyang-si, South Korea
CHA Bundang Medical Center
Gyeonggi-do, South Korea
The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital)
Seocho, South Korea
Seoul National University Bundang Hospital
Seongnam-si, South Korea
Samsung Medical Center
Seoul, South Korea
Severance Hospital - Yonsei Cancer Center
Seoul, South Korea
University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC)
Songpa-gu, South Korea
Institut Catala d?Oncologia Hospital Germans Trias i Pujol
Badalona, Spain
Hospital Regional Universitario de Malaga
Málaga, Spain
Clinica Universitaria de Navarra (CUN)
Pamplona/iruña, Spain
Hospital Universitario Central de Asturias
Oviedo, Spain
Hospital Universitario Vall d Hebron
Barcelona, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Spain
Clinica Universitaria de Navarra de Madrid;Servicio de Hepatologia
Madrid, Spain
Hospital Universitario Ramón y Cajal
Madrid, Spain
Hospital Universitario 12 De Octubre
Madrid, Spain
Centro Integral Oncológico Clara Campal Ensayos Clínicos START
Madrid, Spain
Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden
Karolinska Universitetssjukhuset
Solna, Sweden
Clatterbridge Cancer Centre Liverpool
Liverpool, United Kingdom
Belfast City Hospital
Belfast, United Kingdom
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Addenbrookes Hospital
Cambridge, United Kingdom
Barts Health NHS Trust
London, United Kingdom
Guys Hospital
London, United Kingdom
Imperial College Healthcare NHS Trust - Hammersmith Hospital
London, United Kingdom
University College London Cancer Institute
London, United Kingdom
Trial contact
Reference Study ID Number: GO44479 https://forpatients.roche.com/ No attachments to email below.
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.